July 17, 2017 / 6:27 AM / in 5 months

BRIEF-UDG Healthcare acquires Cambridge Biomarketing

July 17 (Reuters) - UDG Healthcare Plc:

* Says acquisition of Cambridge Biomarketing LLC, a US-based healthcare communications business, for a total consideration of up to $35 mln

* Cambridge Biomarketing is being acquired for an initial consideration of $30 mln, with additional consideration of up to $5 mln Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below